BRPI0512230A - método para minimizar a retenção de pó sobre superfìcies - Google Patents

método para minimizar a retenção de pó sobre superfìcies

Info

Publication number
BRPI0512230A
BRPI0512230A BRPI0512230-9A BRPI0512230A BRPI0512230A BR PI0512230 A BRPI0512230 A BR PI0512230A BR PI0512230 A BRPI0512230 A BR PI0512230A BR PI0512230 A BRPI0512230 A BR PI0512230A
Authority
BR
Brazil
Prior art keywords
dose
dry powder
metered
doses
medical product
Prior art date
Application number
BRPI0512230-9A
Other languages
English (en)
Inventor
Alf Niemi
Sven Calander
Lars Kax
Original Assignee
Mederio Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mederio Ag filed Critical Mederio Ag
Publication of BRPI0512230A publication Critical patent/BRPI0512230A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Abstract

MéTODO PARA MINIMIZAR A RETENçãO DE Pó SOBRE SUPERFìCIES A invenção refere-se a um método para aumentar a saída de pó, isto é, da dose de medicamento emitida por um dispositivo inalador de pó seco, pela minimização da retenção de pó no interior do dispositivo. Também a eficácia terapêutica da dose medida de medicamento é aumentada. Foi determinado que a adição de uma quantidade menor de excipiente que a que seria necessária em uma mistura ordenada a uma dose medida em uma formulação de API aumenta a dose de API emitida quando a dose é inalada juntamente com o excipiente.
BRPI0512230-9A 2004-06-18 2005-05-27 método para minimizar a retenção de pó sobre superfìcies BRPI0512230A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401612A SE530006C2 (sv) 2004-06-18 2004-06-18 Inhalator som använder balja
PCT/SE2005/000795 WO2005123004A1 (en) 2004-06-18 2005-05-27 Minimizing powder retention on surfaces

Publications (1)

Publication Number Publication Date
BRPI0512230A true BRPI0512230A (pt) 2008-02-19

Family

ID=32906844

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0512230-9A BRPI0512230A (pt) 2004-06-18 2005-05-27 método para minimizar a retenção de pó sobre superfìcies
BRPI0512241-4A BRPI0512241A (pt) 2004-06-18 2005-06-09 inalador utilizando casulos

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0512241-4A BRPI0512241A (pt) 2004-06-18 2005-06-09 inalador utilizando casulos

Country Status (17)

Country Link
US (4) US20050279356A1 (pt)
EP (3) EP1768641A1 (pt)
JP (2) JP2008502416A (pt)
KR (2) KR20070034598A (pt)
CN (2) CN101098671A (pt)
AT (1) ATE441402T1 (pt)
AU (3) AU2005253906A1 (pt)
BR (2) BRPI0512230A (pt)
CA (3) CA2569574A1 (pt)
DE (1) DE602005016410D1 (pt)
IL (2) IL179481A0 (pt)
MX (2) MXPA06014502A (pt)
RU (2) RU2006146870A (pt)
SE (1) SE530006C2 (pt)
SG (1) SG138610A1 (pt)
WO (3) WO2005123004A1 (pt)
ZA (3) ZA200700442B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007210177C1 (en) 2006-01-31 2012-11-01 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
JP5241714B2 (ja) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス， インコーポレイテッド スマートな非経口送達システム
GB0616299D0 (en) * 2006-08-16 2006-09-27 Cambridge Consultants Drug Capsules for dry power inhalers
ES2596263T3 (es) * 2006-10-25 2017-01-05 Novartis Ag Aparato de dispersión de polvo
WO2009055733A1 (en) 2007-10-25 2009-04-30 Proteus Biomedical, Inc. Fluid transfer port information system
US8419638B2 (en) 2007-11-19 2013-04-16 Proteus Digital Health, Inc. Body-associated fluid transport structure evaluation devices
SI2400950T1 (sl) 2009-02-26 2019-09-30 Glaxo Group Limited Farmacevtske forlmulacije, ki obsegajo 4-((1 R)-2-((6-(2-((2,6- diklorobenzil)oksi)etoksi)heksil)amino)-1-hidroksietil)-2- (hidroksimetil)fenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
JP5330609B2 (ja) 2010-02-01 2013-10-30 プロテウス デジタル ヘルス， インコーポレイテッド ２つの手首におけるデータ収集システム
CA2788336C (en) 2010-02-01 2018-05-01 Proteus Digital Health, Inc. Data gathering system
WO2014004400A2 (en) * 2012-06-28 2014-01-03 The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Nasal dry powder delivery system for vaccines and other treatment agents
DE102020214431A1 (de) * 2020-11-17 2022-05-19 BSH Hausgeräte GmbH Lebensmittel-Aufnahmebehälter mit spezifischer Koppelvorrichtung zwischen Frontwand und Behälterwanne, sowie Haushaltskältegerät

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591152B2 (en) * 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
HU213221B (en) * 1990-03-02 1997-03-28 Glaxo Group Ltd Inhalation device and medicine packet for device
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
FR2698289B1 (fr) * 1992-11-20 1995-01-27 Airsec Ind Sa Matières déshydratantes à base de polymères.
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
DE69636757T2 (de) * 1995-04-14 2007-10-11 Smithkline Beecham Corp. Dosierinhalator für Fluticasonepropionat
US6130263A (en) * 1995-04-19 2000-10-10 Capitol Specialty Plastics, Inc. Desiccant entrained polymer
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
US6209538B1 (en) * 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
EP0921830B1 (en) * 1996-04-25 2002-09-04 AstraZeneca AB Inhaler
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
US5791487A (en) * 1996-07-17 1998-08-11 Mebane Packaging Group Book-type carton with pull out tray
US6131570A (en) * 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
ATE382386T1 (de) * 1998-11-13 2008-01-15 Jagotec Ag Multidosis-trockenpulverinhalator mit pulverreservoir
SE517806C2 (sv) * 1999-11-11 2002-07-16 Microdrug Ag Doseringsanordning för inhalator
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
US6865012B2 (en) * 2000-03-03 2005-03-08 Sipix Imaging, Inc. Electrophoretic display and novel process for its manufacture
US6971383B2 (en) * 2001-01-24 2005-12-06 University Of North Carolina At Chapel Hill Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
US7080644B2 (en) * 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
SE517513C2 (sv) * 2000-09-25 2002-06-11 Microdrug Ag Gränssnittsarragemang för att säkerställa korrekt dosering samt säker funktion och hantering vid en inhalator för torrt pulver.
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
US7077130B2 (en) * 2000-12-22 2006-07-18 Chrysalis Technologies Incorporated Disposable inhaler system
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
SE522558C2 (sv) * 2001-07-13 2004-02-17 Microdrug Ag Förfarande och anordning för styrning av överföring av elektriskt laddade partiklar av ett medicinskt pulver till en målarea på ett substratelement vid en dosutformningsprocess
WO2003045857A1 (en) * 2001-11-28 2003-06-05 Huntsman Petrochemical Corporation Sulfosuccinamate surfactants as deposition inhibitors
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
WO2004011067A1 (en) * 2002-07-25 2004-02-05 Glaxo Group Limited Medicament dispenser
GB0217198D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems

Also Published As

Publication number Publication date
AU2005253906A1 (en) 2005-12-29
IL179480A0 (en) 2007-05-15
KR20070034598A (ko) 2007-03-28
ZA200700443B (en) 2008-08-27
DE602005016410D1 (de) 2009-10-15
WO2005123002A1 (en) 2005-12-29
CN101098671A (zh) 2008-01-02
EP1765291B1 (en) 2009-09-02
WO2005123038A1 (en) 2005-12-29
CA2570118A1 (en) 2005-12-29
ATE441402T1 (de) 2009-09-15
JP2008502416A (ja) 2008-01-31
BRPI0512241A (pt) 2008-02-19
JP2008502417A (ja) 2008-01-31
US20050287078A1 (en) 2005-12-29
US20070256687A1 (en) 2007-11-08
AU2005253908A1 (en) 2005-12-29
US20050279356A1 (en) 2005-12-22
ZA200700442B (en) 2009-02-25
EP1765291A1 (en) 2007-03-28
MXPA06014501A (es) 2007-03-23
CN1968670A (zh) 2007-05-23
ZA200700441B (en) 2009-04-29
KR20070034596A (ko) 2007-03-28
US20060005832A1 (en) 2006-01-12
EP1768640A1 (en) 2007-04-04
WO2005123004A1 (en) 2005-12-29
CA2569570A1 (en) 2005-12-29
CA2569574A1 (en) 2005-12-29
AU2005253907A1 (en) 2005-12-29
MXPA06014502A (es) 2007-03-12
EP1768641A1 (en) 2007-04-04
RU2006146879A (ru) 2008-07-27
SE0401612L (sv) 2005-12-23
SE0401612D0 (sv) 2004-06-18
RU2006146870A (ru) 2008-07-27
SG138610A1 (en) 2008-01-28
IL179481A0 (en) 2007-05-15
SE530006C2 (sv) 2008-02-05

Similar Documents

Publication Publication Date Title
BRPI0512230A (pt) método para minimizar a retenção de pó sobre superfìcies
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
BRPI0417155A (pt) produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade
SE0402976L (sv) Medicinsk produkt
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
WO2004093848A3 (en) Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
ATE509616T1 (de) Topische pharmazeutische und/oder cosmetische dosierungssysteme
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
WO2007123945A3 (en) Mechanical single dose intrapulmonary drug delivery devices
PT1173244E (pt) Inalador de po para um medicamento combinado
CY1110636T1 (el) Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
CY1119805T1 (el) Συστημα χορηγησης φαρμακων για τη χορηγηση πτωχως υδατοδιαλυτων φαρμακευτικως ενεργων ουσιων
AT510866A3 (de) Stabiles pharmazeutisches kombinationspräparat
SE0402345L (sv) Uppmätt läkemedelsdos
EE200400110A (et) Reguleeritud/pikendatud vabanemisega tahke ravimvorm kui doosi dumpingu vähendatud riskiga uus ravimi manustamissüsteem
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
MD3121F1 (en) Method of viral hepatitis B prophylaxis
AR029096A1 (es) Combinacion de sustancias activas que contiene montirelina y un compuesto de efecto opioide, medicamentos y formulaciones medicamentosas que contienen dicha combinacion y su uso para la preparacion de medicamentos para tratamiento del dolor
AR029327A1 (es) Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en el anestesiamiento de pacientes sujetos a intervencion de cirugia mayor

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.